Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-01-24 @ 5:26 AM
Study NCT ID:
NCT00936260
Status:
COMPLETED
Last Update Posted:
2009-07-10
First Post:
2009-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Sponsor:
Ciudad Universitaria, Spain
Organization:
Study Overview
Official Title:
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Status:
COMPLETED
Status Verified Date:
1998-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.
Detailed Description:
The duration of the treatment with alendronate is not well established. The investigators recruited 228 women with postmenopausal osteoporosis. They all received alendronate during the first 3 years of monitoring and were later on randomized to whether different regimens of intermittent treatment or to carry on 3 years more.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: